Oleanolic acid suppresses resistin induction in adipocytes by modulating Tyk-STAT signaling

Nutrition Research

Volumn 33, Issue 2, 2013, Pages 144-153

  Kim, Hyun Sung ^a   Sung, Hye Young ^a   Kim, Min Soo ^a   Kim, Jung Lye ^a   Kang, Min Kyung ^a   Gong, Ju Hyun ^a   Park, Hyoung Sook ^b   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

^b Hanseo University   (South Korea)

Author keywords

Adipocyte differentiation; Obesity; Oleanolic acid; Resistin; Tyk STAT signaling

Indexed keywords

OLEANOLIC ACID; PROTEIN KINASE TYK2; RESISTIN; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME ACTIVATION; IMMUNOCYTOCHEMISTRY; INFLAMMATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REGULATORY MECHANISM;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; OLEANOLIC ACID; PHOSPHORYLATION; PLANT EXTRACTS; RESISTIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYK2 KINASE;

EID: 84873525790     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.12.006     Document Type: Article

References (26)

1. Belkina A.C., Denis G.V. Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes 2010, 17:472-477.
2. Filková M., Haluzík M., Gay S., Senolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 2009, 133:157-170.
3. Lazar M.A. Resistin- and obesity-associated metabolic diseases. Horm Metab Res 2007, 39:710-716.
4. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
5. Malyszko J., Malyszko J.S., Pawlak K., Mysliwiec M. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc 2006, 38:3434-3436.
6. Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert Opin Pharmacother 2011, 12:1887-1900.
7. Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 2010, 44:25-36.
8. Duvnjak L., Duvnjak M. The metabolic syndrome-an ongoing story. J Physiol Pharmacol 2009, 60(Suppl 7):19-24.
9. Sultana N., Ata A. Oleanolic acid and related derivatives as medicinally important compounds. J Enzyme Inhib Med Chem 2008, 23:739-756.
10. Lin Z., Zhang Y., Zhang Y., Shen H., Hu L., Jiang H., et al. Oleanolic acid derivative NPLC441 potently stimulates glucose transport in 3T3-L1 adipocytes via a multi-target mechanism. Biochem Pharmacol 2008, 76:1251-1262.
11. Sung H.Y., Kang S.W., Kim J.L., Li J., Lee E.S., Gong J.H., et al. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr Res 2010, 30:831-839.
12. Kim M.S., Lee M.S., Kwon D.Y. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Ann NY Acad Sci 2011, 1229:140-146.
13. Juman S., Yasui N., Okuda H., Ueda A., Negishi H., Miki T., et al. Caffeic acid phenethyl ester suppresses the production of adipocytokines, leptin, tumor necrosis factor-alpha and resistin, during differentiation to adipocytes in 3T3-L1 cells. Biol Pharm Bull 2011, 34:490-494.
14. Makino-Wakagi Y., Yoshimura Y., Uzawa Y., Zaima N., Moriyama T., Kawamura Y. Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. Biochem Biophys Res Commun 2012, 417:880-885.
15. Sung H.Y., Jun J.G., Kang S.W., Kim H.S., Shin D., Kang I.J., et al. Novel Danshen methoxybenzo[b]furan derivative antagonizing adipogenic differentiation and production of inflammatory adipokines. Chem Biol Interact 2010, 188:457-466.
16. Park M.Y., Seo D.W., Lee J.Y., Sung M.K., Lee Y.M., Jang H.H., et al. Effects of Panicum miliaceum L. extract on adipogenic transcription factors and fatty acid accumulation in 3T3-L1 adipocytes. Nutr Res Pract 2011, 5:192-197.
17. Park S.H., Park J.H.Y., Kang J.S., Kang Y.H. Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 2003, 35:168-182.
18. Silswal N., Singh A.K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N.Z. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005, 334:1092-1101.
19. Verma S., Li S.H., Wang C.H., Fedak P.W., Li R.K., Weisel R.D., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108:736-740.
20. Sánchez-Solana B., Laborda J., Baladrón V. Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Mol Endocrinol 2012, 26:110-127.
21. Catta-Preta M., Martins M.A., Cunha Brunini T.M., Mendes-Ribeiro A.C., Mandarim-de-Lacerda C.A., Aguila M.B. Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets. Nutrition 2012, 28:212-219.
22. Lefterova M.I., Mullican S.E., Tomaru T., Qatanani M., Schupp M., Lazar M.A. Endoplasmic reticulum stress regulates adipocyte resistin expression. Diabetes 2009, 58:1879-1886.
23. Sun J., Xu Y., Deng H., Sun S., Dai Z., Sun Y. Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. J Mol Endocrinol 2010, 44:179-185.
24. Shehzad A., Ha T., Subhan F., Lee Y.S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr 2011, 50:151-161.
25. Liby K., Voong N., Williams C.R., Risingsong R., Royce D.B., Honda T., et al. The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells. Clin Cancer Res 2006, 12:4288-4293.
26. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001, 19:378-387.